Hydrogen proton magnetic resonance spectroscopy is only beginning to be studied in autistic individuals. We report an association between hydrogen proton magnetic resonance spectroscopy choline/creatine ratios and severity of autism as measured by the Children's Autistic Rating Scale (Pearson r = .657, P = .04) in 10 autistic children. Hydrogen proton magnetic resonance spectroscopy choline/creatine ratio measures the concentration of cytosolic choline including free choline used in the synthesis of acetylcholine. Elevation in this ratio has been interpreted as a result of membrane degradation such as caused by a tumor or, alternatively, as a result of choline synthesis associated with increased cellular proliferation. Recent neuropathologic evidence has implicated disruption of acetylcholine transmission in the brains of autistic adults. A case-controlled study of hydrogen proton magnetic resonance spectroscopy choline/creatine ratios is warranted. (J Child Neurol 2002;17:245-249).
Get full access to this article
View all access options for this article.
References
1.
Bauman M., Kemper TL: Histoanatomic observations of the brain in early infantile autism . Neurology1985;35:866-874.
2.
Filipek PA: Neuroimaging in the developmental disorders: The state of the science . J Child Psychol Psychiatry1999;40:113-128.
3.
Aylward EH, Minshew NJ, Goldstein G., et al: MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology1999;53:2145-2150.
4.
Bolton PF, Griffiths PD: Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet1997;349: 392-395.
5.
DeLong GR, Heinz ER: The clinical syndrome of early-life bilateral hippocampal sclerosis . Ann Neurol1997;42:7-11.
6.
Chiron C., Leboyer M., Leon F., et al: SPECT of the brain in childhood autism: Evidence for a lack of normal hemisphere asymmetry. Dev Med Child Neurol1995;37:849-860.
7.
Mountz JM, Tolbert LC, Lill DW, et al: Functional deficits in autistic disorder: Characterization by technetium-99m-HMPAO and SPECT. J Nucl Med1995;36:1156-1162.
8.
Zilbovicius M., Garreau B., Tzourio N., et al: Regional cerebral blood flow in childhood autism: A SPECT study. Am J Psychiatry149:924-930.
9.
Haznedar MM, Buschsbaum MS, Metzgerm M., et al: Anterior cingulate gyrus volume and glucose metabolism in autistic disorders. Am J Psychiatry1997;154:1047-1050.
10.
Chugani DC, Muzik O., Rothermel R., et al: Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol1997;42:666-669.
11.
Schultz RT, Gauthier I., Klin A., et al: Abnormal ventral temporal activity during face discrimination among individuals with autism and Asperger syndrome. Arch Gen Psychiatry2000;57:331-340.
12.
Hashimoto T. , Tayama M., Miyazaki M., et al: Differences in brain metabolites between patients with autism and mental retardation as detected by in vivo localized proton magnetic resonance spectroscopy. J Child Neurol1997;12:91-96.
13.
Hashimoto T. , Kawano N., Fududa Hashimoto TK, et al: Proton magnetic resonance spectroscopy of the brain in three cases of Rett syndrome: Comparison with autism and normal controls. Acta Neurol Scand1998;98:8-14.
14.
Minshew NJ, Goldstein G., Dombrowski SM, et al: A preliminary 3/P MRS study of autism: Evidence for undersynthesis and increased degradation of brain membranes. Biol Psychiatry1993;762-773.
15.
Perry EK, Lee ML, Martin-Ruiz CM, et al: Cholinergic activity in autism: Abnormalities in the cerebral cortex and basal forebrain. Am. J Psychiatry2001;156:1058-1066.
16.
Parks SL: The assessment of autistic children: A selective review of available instruments . J Autism Dev Disord1983;13:255-267.
17.
Byrd SE, Tomita T., Palka PS, et al: Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, Part II: Clinical analysis. J Natl Med Assoc1996;88:717-723.
18.
Tzika AA, Vajapeyam S., Barnes PD: Multivoxel proton MR spectroscopy and hemodynamic MR imaging of childhood brain tumors: Preliminary observations. AJNR Am J Neuroradiol1997; 18:203-218.
19.
Soher BJ, van Zijl Pcm, Duyn JH, et al: Quantitative proton MR spectroscopic imaging of the human brain . Magn Reson Med1996;35:356-363.
20.
Satlin A., Bodick N., Offen WW, Renshaw PF: Brain proton magnetic resonance spectroscopy in Alzheimer's disease: Changes after treatment with xanomeline, an M sub 1 selective cholinergic agonist . Am J Psychiatry1997;154:1459-1461.
21.
Mackay S., Mayeroff DJ, Constans JM, et al: Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with H-magnetic resonance spectroscopic imaging. Arch Neurol1996; 53:167-174.
22.
Scott RC, Thompson CH, Dixon R., et al: Brain biochemistry in Duchenne muscular dystrophy: A 1 H magnetic resonance and neuropsychological study. J Neurol Sci1998;160:148-157.
23.
Kato T., Nishina M., Matsushita K., et al: Increased cerebral choline-compounds in Duchenne muscular dystrophy . Neuroreport1997; 8:1435-1437.
24.
Kruse B., Barker PB, van Zijl PC, et al: Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy. Ann Neurol1994:36:595-608.
25.
Engelbrecht V., Rassek M., Gartner J., et al: The value of new MRI techniques in adrenoleukodystrophy. Pediatr Radiol1997;27: 207-215.
26.
Meyerhoff DJ , MacKay S., Constans JM, et al: Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol1994;36:40-47.
27.
Corchese E. , Karris CM, Devis HR, et al: Unusual brain growth patterns in early life inpatients with autistic disorder, an MRI study . Neurology2001;57:245-254.
28.
Nelson KB, Grether JK, Croen LA, et al: Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol2001;49:597-606.
29.
Noworolski SM, Nelson SJ, Henry RG, et al: High spatial resolution H-MRS and segmented MR1 of cortical gray matter and subcortical white matter in three regions of the human brain. Magn Reson Med1999;41:21-29.
30.
Byrd SE, Tomita T., Palka PS, et al: Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, Part 1: Introduction to MRS. J Natl Med Assoc1996;88:649-654.
31.
Hashimoto T. , Tayama M., Miyazaki M., et al: Developmental brain changes investigated with proton magnetic resonance spectroscopy. Dev Med Child Neurol1995;37:398-405.
32.
Jackson EF, Myers CA: Introduction to hippocampal spectroscopy. Neuroimaging Clin North Am1997;7:143-154.
